AI assistant
AstraZeneca PLC — Director's Dealing 2013
Feb 27, 2013
5229_dirs_2013-02-27_bf97325f-a02e-4da4-b3a8-da2902f59615.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 7729Y
AstraZeneca PLC
27 February 2013
Transaction by Person Discharging Managerial Responsibilities
Disclosure Rule DTR 3.1.4
The interest of Pascal Soriot, a Director of the Company, in AstraZeneca PLC Ordinary Shares of $0.25 each, has changed as detailed below.
On 25 February 2013, Mr Soriot received an award of 3,799 shares under the AstraZeneca Deferred Bonus Plan. This award relates to the payment of his annual bonus whereby he is required to defer a portion of the bonus earned into shares for a period of three years. The shares were allocated at a price of 2939 pence per share. Mr Soriot will become beneficially entitled to these shares on 25 February 2016.
As a result of this transaction, Mr Soriot has an interest in 145,515 Ordinary Shares, which represent approximately 0.01% of the Company's issued ordinary capital.
A C N Kemp
Company Secretary
27 February 2013
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSUBAKROVAUURR